Unified Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.34M Buy
10,446
+306
+3% +$35.8K 1.24% 22
2026
Q1
$1.22M Sell
10,140
-184
-2% -$21.2K 1.25% 22
2025
Q4
$1.09M Buy
10,324
+20
+0.2% +$1.88K 1.09% 22
2025
Q3
$865K Buy
10,304
+139
+1% +$11.4K 0.86% 35
2025
Q2
$805K Buy
10,165
+674
+7% +$53.6K 0.86% 38
2025
Q1
$852K Buy
+9,491
New +$886K 1.01% 31

Other funds holding MRK

Unified Investment Management's MRK Position: Q2 2026 in Review

Unified Investment Management increased its Merck (MRK) stake by 3% in Q2 2026, buying an estimated $35.8K and bringing the position to 10,446 shares worth $1.34M. The position accounts for 1.24% of the portfolio, ranked #22.

Unified Investment Management first reported a position in MRK in Q1 2025 and has held it in 6 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Unified Investment Management held 10,446 shares of Merck worth $1.34M as of Q2 2026.
  • Unified Investment Management bought 306 Merck shares in Q2 2026, an estimated $35.8K.
  • Merck made up 1.24% of Unified Investment Management's portfolio in Q2 2026, its #22 holding.
  • Unified Investment Management first reported a position in Merck in Q1 2025 and has held it in 6 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Unified Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.